For treating diabetes, Levemir® and Victoza®, myristic acid derivatives of human insulin or glucagon-like peptide 1 (GLP-1), act as long-acting peptides by binding to the fatty acid binding sites on circulating albumin in order to control glucose levels. The gene discussed is GCG; the disease is diabetes mellitus.